Dravet syndrome Market Trends, Industry Segments, Landscape and Demand by 2027

 Dravet syndrome market research information: by type of seizures (myoclonic, partial, absence seizures), diagnosis (MRI, EEG, SCN1A testing), treatment (seizure medications, ketogenic diet, vagus nerve stimulation), end-user – forecast till 2027

Dravet syndrome is a rare genetic epileptic encephalopathy that begins during the first year of life in an otherwise healthy infant. According to the National Center for Advancing Translational Sciences, in 15% to 25% cases of the Dravet syndrome, a family history of epilepsy or febrile seizures exists. It is also reported that 85% cases of Dravet syndrome originated due to a mutation in the SCN1A gene.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5509

Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the global Dravet syndrome market.

Despite these drivers, there are some issues associated with Dravet syndrome market. The side effects of drugs and other therapeutic agents, lack of awareness in the developing countries, and poor healthcare system in low and middle-income countries, may hinder the growth of the market.

It is estimated that the Dravet syndrome market is expected to grow at a CAGR of 8.5% during the forecast period, 2017-2023.

Key Players:

Some of key the players in the global dravet syndrome market are Biocodex, Biscayne Neurotherapeutics, Cyberonics, Inc., Epygenix Therapeutics, Inc., GW Pharmaceuticals, plc, INSYS THERAPEUTICS, INC., OPKO Health Inc., Ovid Therapeutics, PTC Therapeutics, Sage Therapeutics, Takeda Pharmaceutical Company Limited, Thermo Fisher Life Technologies, Xenon Pharmaceuticals, Zogenix, Inc, and others.

Segmentation:

The global Dravet syndrome market is segmented on the basis of the type of seizures, diagnosis, treatment & management, and end-user.

On the basis of the type of seizures, the market is classified as myoclonic seizures, atonic seizures, partial seizures, absence seizures, tonic clonic seizures, photosensitive seizures, and others.

On the basis of the diagnosis, the market is classified as magnetic resonance imaging (MRI), electroencephalography (EEG), SCN1A testing, and others.

On the basis of the treatment & management, the market is classified as seizure medications, ketogenic diet, vagus nerve stimulation (VNS), and others. The seizure medications segment is further classified into clobazam, stiripentol, sodium valproate, and others.

On the basis of the end-user, the market is segmented into pharmaceutical companies, hospitals, diagnostic laboratories, academic and research institutes, and others.

Regional Analysis:

The Americas dominate the Dravet syndrome market owing to the presence of a large number of leading market players, rising development of new drugs, and high healthcare expenditure. Various US-based pharmaceutical companies such as Zogenix, Inc., Insys Therapeutics, Inc., and OPKO Health, Inc. are continuously putting efforts to come up with novel drugs to control Dravet syndrome and related complications.

Europe holds the second position in the Dravet syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.

Asia Pacific is the fastest growing Dravet syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dravet-syndrome-market-5509

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Comments

Post a Comment

Popular posts from this blog

Root Canal Market share Valuation, Trends and Forecast to 2027

  The Global Root Canal Market could touch the valuation of USD 21.0 billion by 2023, asserts Market Research Future (MRFR). It is expected to achieve a CAGR of 8.0 % during the forecast period (2017-2023). Growth Drivers and Key Barriers The global root canal market benefits from the rising demand for the treatment owing to the expanding population and the subsequent surge in the number of procedures performed. The boost in number of screenings, greater stress on restorative dental procedures, greater consumption of starch-rich diets and fast foods and rising efficacy, efficiency and success rate of root canal treatment has taken the market to greater heights.  Having said that, the high cost of root canal treatment could act as a barrier for the market in the near future. However, as product development is one of the best strategies for market growth, the market could observe exponential growth in the coming years. This factor stands true on the back of technological advancements
Read more

Cardiovascular Ultrasound Market,Growth, Demand and Key Players to 2027

  GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Cardiovascular Ultrasound Market and are profiled in MRFR Analysis.  Global Cardiovascular Ultrasound  Market - Overview Cardiovascular ultrasound imaging system market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favouring the growth of this market. Increase in demand of cardiovascular ultrasound imaging system in hospitals for diagnosis of heart disease or before any surgical procedure favour the growth of this market.     Cardiovascular diseases gain a huge attention due to increasing prevalence. Due to increasing number of death from cardiovascular diseases, number of companies are in a race for the introduction of th
Read more

Root Canal Market Leading Players, Sales Projection and COVID-19 Impact Analysis By 2027

  Market Scenario A root canal is a dental procedure involving the removal of the central pulp from the tooth. A root canal is performed when the pulp of a tooth is injured, inflamed or infected. The objective of the root canal is to save the structure of the tooth and to prevent infection of the gums and other teeth. Common causes of the root canal treatment include deep decay due to the cavity, a chip or crack in the tooth, an injury to the tooth, infection, and others. The most common symptoms of damaged pulp include pain, swelling, and a heat sensation in the gums. also read @  http://www.marketwatch.com/story/root-canal-market-trends-size-share-demand-forecast-business-revenue-investment-opportunities-competitor-strategies-and-impact-of-covid-19-2021-01-17 Growth Drivers and Key Barriers The global root canal market benefits from the rising demand for the treatment owing to the expanding population and the subsequent surge in the number of procedures performed. The boost in nu
Read more